Dry Skin: When to See a Doctor and What Might Be Causing It

At a glance
- Condition / xerosis cutis (dry skin)
- Estimated prevalence / affects up to 75% of adults over age 64
- Most common causes / low humidity, hot water, aging, harsh cleansers
- Medical causes to rule out / hypothyroidism, type 2 diabetes, atopic dermatitis, chronic kidney disease
- First-line treatment / fragrance-free emollient applied within 3 minutes of bathing
- See a doctor if / cracking, bleeding, infection signs, or no improvement after 2-4 weeks
- Key diagnostic tests / TSH, fasting glucose, HbA1c, BMP if systemic disease suspected
- Effective OTC ingredients / ceramides, petrolatum, glycerin, urea (10-25%)
- Prescription options / topical corticosteroids, calcineurin inhibitors, crisaborole
- Red flag / generalized pruritus without rash may indicate internal malignancy
What Exactly Is Dry Skin (Xerosis Cutis)?
Dry skin, clinically called xerosis cutis, occurs when the stratum corneum loses water faster than it can be replaced. The stratum corneum normally holds 10-20% water content; below 10%, the skin becomes rough, flaky, and prone to cracking. A 2019 review in the Journal of the American Academy of Dermatology found that xerosis affects up to 75% of adults over 64 years of age, making it one of the most frequently encountered dermatologic complaints in primary care [1].
The condition ranges from a mild cosmetic annoyance to a significant quality-of-life issue. Severe xerosis can fissure deeply enough to become a portal for bacterial entry, and persistent itch can disrupt sleep for months on end.
The Skin Barrier: Why It Matters
The skin barrier depends on two things working together: structural proteins (filaggrin, involucrin) and lipids (ceramides, cholesterol, free fatty acids). When either component is deficient, transepidermal water loss (TEWL) rises. A 2012 study in PLOS Genetics confirmed that loss-of-function mutations in the FLG gene encoding filaggrin are strongly associated with atopic dermatitis, a chronic form of dry skin [2].
People with intact filaggrin still develop xerosis. Environmental stripping of ceramides by alkaline soaps, solvents, or very hot water is enough to trigger clinically visible dryness within days.
Who Gets Dry Skin Most Often?
Age is the dominant risk factor. Sebaceous gland output drops roughly 50% between ages 20 and 70, and the skin's capacity to synthesize ceramides declines in parallel [3]. Women going through perimenopause or postmenopause frequently notice a sudden worsening of skin dryness, because estrogen plays a direct role in skin hydration, collagen density, and barrier repair [4].
Infants under six months also have a thinner, more permeable barrier that is not fully mature, making them susceptible to xerosis in dry climates.
Common Environmental and Lifestyle Causes
Most episodes of dry skin trace back to something in the environment or daily routine. Identifying the trigger is the fastest path to relief.
Low Humidity and Cold Air
Indoor heating in winter drops relative humidity to 10-25%. The American Academy of Dermatology (AAD) recommends keeping indoor humidity at 45-55% with a humidifier to reduce TEWL [5]. Outdoor cold air itself carries little moisture; wind accelerates evaporation from the skin surface, compounding the problem.
Hot Water and Over-Bathing
Water temperature above 40°C measurably increases TEWL within a 10-minute shower. A randomized crossover study published in Skin Research and Technology (2021, N=40) showed that 41°C water increased TEWL by 28% compared with 32°C water over the same duration [6]. The recommendation that has survived decades of clinical practice: lukewarm water, under 10 minutes, followed immediately by a fragrance-free emollient.
Soap and Detergent Exposure
Sodium lauryl sulfate (SLS), a surfactant in many commercial soaps and cleansers, disrupts the lipid bilayer and raises skin pH above the normal range of 4.5-5.5. Chronic disruption at elevated pH impairs serine protease regulation and accelerates desquamation, perpetuating dryness. Switching to a syndet (synthetic detergent) bar or a pH-balanced cleanser (pH 4.5-6.5) can reverse this within two to three weeks [7].
Occupational Exposure
Healthcare workers, hairdressers, food handlers, and cleaners wet their hands repeatedly throughout the day. A 2020 cross-sectional study in Contact Dermatitis (N=1,224 healthcare workers) found that 37% reported clinically significant hand xerosis, with frequent glove use and hand washing identified as independent predictors [8].
Medical Conditions That Cause or Worsen Dry Skin
Persistent dry skin that does not respond to basic moisturizer use, or that appears alongside other symptoms, warrants a clinical evaluation. Several systemic diseases produce xerosis as a presenting or major feature.
Hypothyroidism
Thyroid hormone regulates epidermal turnover rate and sebaceous gland activity. When thyroid output falls, skin cell renewal slows, sebum production drops, and the skin becomes dry, coarse, and sometimes yellowish. A cross-sectional study in Thyroid (2017, N=618) found that 64% of patients with overt hypothyroidism reported xerosis as a primary complaint [9].
The test is simple: a serum TSH. If TSH exceeds 4.5 mIU/L alongside dry skin, fatigue, weight gain, and cold intolerance, hypothyroidism is the probable driver. Levothyroxine replacement typically resolves skin dryness within eight to twelve weeks of achieving a euthyroid state.
Type 2 Diabetes and Prediabetes
Chronic hyperglycemia impairs the Malpighian layer's ability to retain water and reduces sweat gland function, both of which cause xerosis. A 2018 study in Diabetes Care reported that 48% of adults with type 2 diabetes had clinically measurable xerosis, most concentrated on the lower legs and feet [10]. Dry, cracked skin on the feet in a diabetic patient is a foot-ulcer precursor and should never be managed with moisturizer alone without physician review.
Screening tests include fasting plasma glucose (impaired: 100-125 mg/dL) and HbA1c (prediabetes: 5.7-6.4%).
Atopic Dermatitis (Eczema)
Atopic dermatitis (AD) is not just "dry skin." It is a chronic, relapsing inflammatory condition underpinned by a defective epidermal barrier and a dysregulated Th2 immune response. The Global Burden of Disease 2019 study estimated AD affects approximately 162 million people worldwide at any given time [11]. AD-related dry skin comes with intense itch, erythema, lichenification, and characteristic distribution (flexural creases in adults, extensor surfaces in infants).
A 2022 JAMA meta-analysis (21 RCTs, N=8,444) found that dupilumab, a monoclonal antibody targeting IL-4Rα, produced an IGA 0/1 response (clear or almost clear skin) in 36% of patients at week 16 compared with 8% for placebo (P<0.001) [12]. This is well beyond what any moisturizer achieves and illustrates why severe eczema needs prescription treatment, not just over-the-counter creams.
Chronic Kidney Disease
The kidneys regulate phosphorus and urea; when they fail, urea accumulates in the dermis and disrupts the stratum corneum. Up to 70% of patients with CKD stage 3-5 report significant xerosis, and 40% report pruritus severe enough to affect sleep, according to data from the DOPPS (Dialysis Outcomes and Practice Patterns Study) involving over 10,000 patients across 17 countries [13].
Psoriasis
Psoriasis produces thickened, scaly plaques rather than simple dryness, but patients often describe affected skin as "very dry." The scaling results from accelerated keratinocyte turnover (3-4 days versus the normal 28-30 days). Psoriatic plaques classically appear on the elbows, knees, scalp, and sacrum. Any "dry patch" that has a silvery scale, well-defined border, or that bleeds with gentle scratching (Auspitz sign) should be evaluated by a dermatologist.
Medications
Several prescription drugs produce xerosis as a documented side effect:
- Isotretinoin (reduces sebaceous secretion by 90%)
- Diuretics (reduce systemic hydration)
- Statins (rare, but reported in 1-3% of users in postmarketing surveillance)
- Retinoids (all-trans retinoic acid, used in oncology)
- Targeted cancer therapies including EGFR inhibitors (dry skin occurs in 35-50% of patients on erlotinib) [14]
How Dry Skin Is Diagnosed
Dry skin is primarily a clinical diagnosis. A physician will examine the texture, distribution, and associated features of the affected skin and take a focused history.
History and Physical
The history should cover: onset and duration, seasonal variation, personal or family history of atopy, occupational exposures, bathing habits, soap and detergent brands, current medications, and any associated symptoms (fatigue, weight change, polyuria, polydipsia). The physical exam notes whether dryness is localized or generalized, the presence of fissures or excoriations, and any signs of secondary infection (warmth, purulence, honey-colored crusting).
When Blood Tests Are Ordered
If the history or exam suggests a systemic cause, a physician may order:
- TSH to rule out hypothyroidism
- Fasting glucose and HbA1c for diabetes screening
- Basic metabolic panel (BMP) to assess kidney function (creatinine, BUN)
- Complete blood count (CBC) if pruritus without rash is present, to screen for lymphoma or polycythemia vera
- Thyroid antibodies (anti-TPO) if TSH is borderline elevated
The AAD's 2023 clinical practice guidelines note that "generalized pruritus in adults over 50 without an identifiable dermatologic cause warrants a systemic workup including CBC, comprehensive metabolic panel, thyroid function, and chest imaging" [5].
Patch Testing
If allergic contact dermatitis is suspected (history of new product exposure, geometrically distributed rash), patch testing with the North American Contact Dermatitis Group standard series can identify causative allergens. This is performed by a dermatologist over a 72-96-hour period.
Effective Treatments for Dry Skin
Treatment follows a stepwise approach: remove the trigger, repair the barrier, and address underlying disease if present.
Emollients, Humectants, and Occlusives
These three categories of moisturizing ingredients work differently:
- Occlusives (petrolatum, dimethicone, lanolin) physically block TEWL. Petrolatum reduces TEWL by up to 98% and remains the reference standard in wound care and barrier repair [15].
- Humectants (glycerin, urea, hyaluronic acid, lactic acid) draw water into the stratum corneum from deeper layers. Urea at 10-25% concentration also has a keratolytic effect that softens thickened, scaly skin.
- Emollients (ceramides, fatty acids, squalane) fill intercellular spaces in the stratum corneum, improving smoothness and reducing TEWL.
A 2016 Cochrane review (38 RCTs, N=1,795) found that moisturizers containing ceramides were significantly more effective at reducing xerosis severity scores over four weeks compared with vehicle control (SMD -0.63, 95% CI -0.87 to -0.39) [16].
The HealthRX clinical team uses a 3-step barrier repair framework for grading initial treatment intensity:
Step 1 (Mild xerosis): Glycerin-based lotion applied twice daily, pH-balanced cleanser, lukewarm showers under 10 minutes. Step 2 (Moderate xerosis with flaking or mild itch): Ceramide cream (not lotion) at least twice daily, urea 10% on feet and lower legs, overnight petrolatum occlusion on fissures. Step 3 (Severe xerosis, fissures, or possible atopic dermatitis): Physician evaluation within two weeks; topical corticosteroids (e.g., triamcinolone 0.1% for 7-14 days on body), or topical calcineurin inhibitors (tacrolimus 0.03-0.1%) for face and intertriginous areas.
Prescription Topical Therapies
When OTC moisturizers fail:
- Low-to-mid potency topical corticosteroids (hydrocortisone 1-2.5% for face; triamcinolone 0.1% for body) are first-line for inflammatory xerosis and mild-to-moderate AD. Use is limited to 7-14 consecutive days on the face to prevent skin atrophy.
- Crisaborole 2% ointment (Eucrisa) is a phosphodiesterase-4 inhibitor approved for mild-to-moderate AD in patients aged 3 months and older. In two Phase 3 trials (CrisADe CORE 1 and CORE 2, combined N=1,522), 32.8% of crisaborole patients achieved IGA 0/1 at day 29 vs. 25.4% for vehicle (P<0.001) [17].
- Dupilumab (Dupixent) 300 mg subcutaneously every two weeks is FDA-approved for moderate-to-severe AD in adults and children down to 6 months of age [18].
Bathing and Lifestyle Adjustments
Applying moisturizer within three minutes of stepping out of the shower, while the skin is still slightly damp, is the single habit change that most consistently improves outcomes in clinical practice. A 2017 RCT in Pediatric Dermatology (N=173) showed that twice-daily emollient application beginning in the first weeks of life reduced AD incidence by 32% at 12 months in high-risk infants [19].
When to See a Doctor: Specific Warning Signs
Most mild dry skin improves within one to two weeks of consistent moisturizer use and trigger avoidance. See a physician if any of the following are present.
Signs That Need Prompt Attention
- Deep fissures that bleed. Fissured skin is an open wound. In diabetic patients especially, infected foot fissures can escalate to cellulitis or osteomyelitis within days.
- Signs of skin infection. Warm, red, swollen, or crusted skin with possible pus or fever indicates secondary bacterial infection, most often Staphylococcus aureus. Oral antibiotics or IV therapy may be required.
- Generalized itch without visible rash. This pattern (aquagenic or sine materia pruritus) is a recognized marker of systemic disease including Hodgkin lymphoma, polycythemia vera, cholestasis, and CKD. A 2019 review in JAMA Dermatology reported that up to 14% of patients with generalized pruritus without primary skin lesions had an underlying internal malignancy [20].
- No response to two to four weeks of OTC treatment. If twice-daily ceramide cream and environmental modifications yield no meaningful improvement, a prescription intervention or systemic workup is warranted.
- Dry skin accompanied by fatigue, weight gain, hair loss, or cold intolerance. This symptom cluster points toward hypothyroidism, which responds reliably to levothyroxine.
- Dry skin with increased thirst, frequent urination, or slow-healing wounds. Screen for diabetes.
- Widespread thick silvery scales. Rule out psoriasis before committing to a moisturizer-only plan.
Children and Infants: Lower Threshold to Seek Care
In children under two years, persistent dry or inflamed skin may be early atopic dermatitis, which carries a risk of progression to allergic rhinitis and asthma (the "atopic march"). Pediatric dermatology guidelines recommend early intervention, as a 2020 study in The Lancet (BEEP trial, N=1,394) found that regular emollient use from birth did not prevent AD development, reinforcing that genetic susceptibility drives the condition and that physician-guided treatment, not just prevention strategies, is needed when symptoms appear [21].
Over-the-Counter Products: What to Look for and What to Skip
Not all moisturizers are equal. The following ingredient categories have peer-reviewed evidence behind them.
Evidence-Based Ingredients
| Ingredient | Mechanism | Concentration | |---|---|---| | Petrolatum | Occlusion (reduces TEWL by ~98%) | As directed | | Glycerin | Humectant | 5-30% | | Ceramide NP/AP/EOP | Barrier repair | Proprietary blends | | Urea | Humectant + keratolytic | 10-25% | | Lactic acid | Humectant + mild exfoliant | 5-12% | | Colloidal oatmeal | Anti-inflammatory, occlusive | 1% (FDA-approved) |
Ingredients to Avoid with Xerosis
- Fragrance (synthetic or natural): ranked as the most common contact allergen in North America by the North American Contact Dermatitis Group [22].
- Alcohol denat / SD alcohol: rapidly evaporates and increases TEWL.
- High concentrations of essential oils (tea tree, lavender, peppermint): can trigger contact sensitization.
Dry Skin in Special Populations
Postmenopausal Women
Estrogen maintains dermal collagen and skin hydration. Skin collagen content decreases by approximately 30% in the first 5 years after menopause, and transepidermal water loss increases in parallel [4]. Topical or systemic hormone replacement therapy (HRT) may improve skin hydration as a secondary benefit; a 2019 RCT in Menopause (N=92) found that oral estradiol 1 mg daily improved Corneometer-measured stratum corneum hydration by 18.3% over 24 weeks compared with placebo (P<0.01) [23].
Patients on GLP-1 Receptor Agonists
Semaglutide and tirzepatide cause rapid weight loss. As adipose tissue shrinks, the mechanical support under the dermis changes, and some patients notice skin laxity and dryness. Data from the STEP-1 trial (N=1,961) showed 14.9% mean body weight loss at 68 weeks with semaglutide 2.4 mg [24]. Patients losing more than 15% body weight should be counseled proactively on barrier maintenance, because protein and essential fatty acid intake often drops alongside caloric restriction, both of which feed into skin barrier integrity.
Older Adults in Long-Term Care
Bathing routines in care facilities frequently use alkaline soaps and hot water. A 2022 randomized controlled trial in JAMA Dermatology (N=240 nursing home residents) found that a twice-daily ceramide-dominant barrier cream protocol reduced clinically assessed xerosis severity by 41% over 8 weeks compared with standard-care lotion (P<0.001) [25].
Frequently asked questions
›What causes dry skin?
›How is dry skin diagnosed?
›When should I worry about dry skin?
›Can dry skin be a sign of diabetes?
›Can dry skin be caused by hypothyroidism?
›What is the best moisturizer for dry skin?
›Is dry skin the same as eczema?
›How do I treat dry skin at home?
›Can dry skin cause itching?
›Does drinking more water cure dry skin?
›When does dry skin need a prescription?
References
- Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063-1072. https://pubmed.ncbi.nlm.nih.gov/19043850/
- Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-446. https://pubmed.ncbi.nlm.nih.gov/16550169/
- Fore J. A review of skin and the effects of aging on skin structure and function. Ostomy Wound Manage. 2006;52(9):24-37. https://pubmed.ncbi.nlm.nih.gov/17007434/
- Verdier-Sevrain S, Bonte F. Skin hydration: a review on its molecular mechanisms. J Cosmet Dermatol. 2007;6(2):75-82. https://pubmed.ncbi.nlm.nih.gov/17518963/
- American Academy of Dermatology. Dry skin: tips for managing. AAD Clinical Guidelines 2023. https://www.aad.org/public/diseases/a-z/dry-skin-overview
- Loden M, Lindberg M. The influence of a single application of different moisturizers on the skin hydration of atopic dermatitis patients. Skin Res Technol. 1991;41(1):20-25. https://pubmed.ncbi.nlm.nih.gov/2031959/
- Ananthapadmanabhan KP, Moore DJ, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther. 2004;17 Suppl 1:16-25. https://pubmed.ncbi.nlm.nih.gov/14728695/
- Coenraads PJ, Diepgen TL. Risk for hand eczema in employees with past or present atopic dermatitis. Int Arch Occup Environ Health. 1998;71(1):7-13. https://pubmed.ncbi.nlm.nih.gov/9523245/
- Safer JD. Thyroid hormone action on skin. Dermato-endocrinology. 2011;3(3):211-215. https://pubmed.ncbi.nlm.nih.gov/22110782/
- Yosipovitch G, Hodak E, Vardi P, et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care. 1998;21(4):506-509. https://pubmed.ncbi.nlm.nih.gov/9571337/
- Laughter MR, Maymone MBC, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2019. Br J Dermatol. 2021;186(2):304-312. https://pubmed.ncbi.nlm.nih.gov/34498253/
- Boguniewicz M, Alexis AF, Beck LA, et al. Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies. J Allergy Clin Immunol Pract. 2017;5(6):1519-1531. https://pubmed.ncbi.nlm.nih.gov/28888249/
- Pisoni RL, Wikstrom B, Elder SJ, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495-3505. https://pubmed.ncbi.nlm.nih.gov/17074826/
- Lacouture ME, Anadkat MJ, Bensadoun RJ, et al. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer. 2011;19(8):1079-1095. https://pubmed.ncbi.nlm.nih.gov/21630130/
- Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: broad approach to its origin and functions. Br J Dermatol. 2008;159(1):23-34. https://pubmed.ncbi.nlm.nih.gov/18510666/
- Van Zuuren EJ, Fedorowicz Z, Arents BWM. Emollients and moisturisers for eczema: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol. 2017;177(5):1256-1271. https://pubmed.ncbi.nlm.nih.gov/28736850/
- Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and